Lv5
1130 积分 2022-02-28 加入
探讨临床药师参与新型抗肿瘤药物合理使用的切入点
8天前
已完结
临床药师参与新型抗肿瘤药物合理使用的切入点分析
8天前
已完结
临床药师参与抗肿瘤药物临床合理使用的实践与思考
8天前
已完结
《2022年中国肺癌患者生存质量白皮书》要点解读
8天前
已关闭
中国原发性肺癌规范诊疗质量控制指标(2022版)
8天前
已完结
Artificial intelligence: opportunities in lung cancer
8天前
已完结
Efficacy and safety of first-line lorlatinib versus crizotinib in patients with advanced, ALK-positive non-small-cell lung cancer: updated analysis of data from the phase 3, randomised, open-label CROWN study
8天前
已完结
New options and open issues in the management of unresectable stage III and in early-stage NSCLC: A report from an expert panel of Italian medical and radiation oncologists – INTERACTION group
9天前
已完结
The landscape of cancer research and cancer care in China
9天前
已完结
脂肪肝的流行病学研究进展
10天前
已完结
皖公网安备34019202002308
